News | August 03, 2025
FDA restrict 7-OH opioid products to protect consumers
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The submission is supported by results from the Phase 3b APEX study
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
For patients with resectable early-stage gastric and gastroesophageal junction cancers
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
Subscribe To Our Newsletter & Stay Updated
